期刊文献+

6-羟基多巴胺诱导帕金森病大鼠相关蛋白及mRNA的表达 被引量:3

Expression of related protein and mRNA in 6-hydroxydopamine-induced Parkinson's disease rats
暂未订购
导出
摘要 目的:研究双点法注射6-羟基多巴胺(6-OHDA)制备的帕金森病(PD)大鼠相关分子的改变。方法:采用脑立体定位仪6-OHDA微量注射建立大鼠PD模型,2周后注射阿朴吗啡(APO),观察其行为学改变,并利用高效液相-电化学法测定正常大鼠(n=10)及PD大鼠(n=23)黑质组织中多巴胺(DA)及其代谢物3,4-二羟基苯乙酸(DOPAC)的含量;分光光度法测定超氧化物歧化酶(SOD)活性及丙二醛(MDA)含量;RT-PCR法测定bcl-2和baxmRAN的表达。结果:与正常大鼠比较,PD大鼠黑质组织中DA及其代谢物DOPAC的含量降低(t=17.069和17.087,P均<0.001),SOD活性降低(t=6.314,P<0.001),MDA含量升高(t=11.060,P<0.001),bcl-2mRNA表达降低(t=9.333,P<0.001),而bax mRNA表达则升高(t=6.504,P<0.001)。结论:PD的发生与氧自由基损伤导致的神经元退变有关。 Aim:To investigate the changes of related molecules in Parkinson's disease(PD) rats induced by 6-hydroxydopamine(6-OHDA).Methods:PD models were established by microinjection of 6-OHDA solution into the substantia nigra of the right side of the brain.Then the behavior changes of rats were observed.The contents of DA and DOPAC were measured by HPLC-ED.SOD activity and MDA content were obtained by scenery spectrophotometry.The mRNA expressions of bcl-2 and bax were detected in substantia nigra by RT-PCR.Results:Compared with those of the normal rats,the levels of DOPAC and DA in substantia nigra of PD rats were decreased(t=17.069 and 17.087,P0.001),the SOD activity was lower(t=6.314,P0.001),the content of MDA was on the contrary(t=11.060,P0.001),the expression of bcl-2 decreased(t=9.333,P0.001),but the expression of bax increased in the PD rats(t=6.504,P0.001).Conclusion:PD may be related with oxygen free radicals and neuronal degeneration.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2011年第2期222-225,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 帕金森病 6-羟基多巴胺 多巴胺 超氧化物歧化酶 大鼠 Parkinson's disease 6-hydroxydopamine dopamine SOD rat
  • 相关文献

参考文献10

  • 1崔海燕,刘健,王涛,李旭光,戎浩.帕金森病模型大鼠背外侧被盖核神经元电活动的变化[J].西安交通大学学报(医学版),2010,31(3):306-309. 被引量:2
  • 2田明秀,常明,朱本清,解洪荣,王丹平,张春光,胡林森.多巴胺诱导SH-SY5Y细胞帕金森病模型中GRP78的表达[J].吉林大学学报(医学版),2010,36(1):76-80. 被引量:3
  • 3M. A. Cenci.Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease[J]. Amino Acids . 2002 (1-3)
  • 4Peng J,Andersen JK.Mutantα-synuclein and aging reduce neurogenesis in the acute1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease. Aging Cell . 2010
  • 5Deumens R,Blokland A,Prickaerts J.Modeling Parkinson’s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Experimental Neurology . 2002
  • 6Glinka Y,Tipton KF,Youdim MB.Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine. European Journal of Pharmacology . 1998
  • 7Soto-Otero R,Mendez-Alvarez E,Hermida-Ameijeiras A,et al.Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson’s disease. Journal of Neurophysiology . 2000
  • 8Cory S,Adams JM.Killing cancer cells by flipping the bcl-2/bax switch. Cancer Cell . 2005
  • 9Chan S L,Yu V C.Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities. Clinical and Experimental Pharmacology and Physiology . 2004
  • 10Goren,B.,Kahveci,N.,Eyigor,O.,Alkan,T.,Korfali,E.,Ozluk,K.Effects of intranigral vs intrastriatal fetal mesencephalic neural grafts on motor behavior disorders in a rat Parkinson model. Surgical Neurology . 2005

二级参考文献21

  • 1Baron P. Clinical strategies to prevent and delay motor complicati-ons [ J ]. Neurology, 2003, 61 ( 6 Suppl3 ): S12-16.
  • 2Maguire-Zeiss KA, Short DW, Federoff HJ. Synuclein dopamine and oxidative stress: co-conspirators in Parkinson's disease [ J ]. Brain Res Mol Brain Res, 2005, 134 (1): 18-23.
  • 3Emdadul HM, Asanuma M, Higashi Y, et al. Apoptosis-inducing neurotoxicity of dopamine and its metabolits via reactive quinine genertion in neuroblastoma cells[J].Biochim Biophys Acta, 2003, 1619 (1): 39-52.
  • 4Offen D, Gorodin S, Melanmed E, et al. Dopamine-melanin is actively phagocytized by PC12 cells and cerebellar granular cells: Possible implication's for the etiology of Parkinson's disease [J]. NeurosciLett, 1999, 260 (2):101-104.
  • 5Moore DJ, West AB, Dawson VL, et al. Molecular pathophysioligy of Parkinson's disease [J]. Annu Rev Neurosci, 2005, 28 (6): 57-58.
  • 6Canet-Aviles RM, Wilson MA, Miller DW et al. The Parkinson's disease associated DJ _ 1 protein is neuroprotective due to cysteine-sufinic acid-driven mitochondrial localization[J]. Hum Mol Genet, 2004, 101 (24): 9103 -9108.
  • 7Nakagawa T, Zhu H, Morishima N, et al. Caspase-12 mediates endoplasmic reticulum specific apoptosis and cytotoxicity by amyloibeta[J]. Nature, 2000, 403 (6765): 98-103.
  • 8Kim TD, Choi E, Rhim H, et al. α- synuclein has structural and fu-netion similarities to small heat shock proteins[J]. Biochem Biophys Res Commun, 2004, 324 (4): 1352 -1359.
  • 9Daugaard M, Rohde M. The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions [J]. FEBS Lett, 2007, 581 (19): 3702-3710.
  • 10Nouhi Z, Chevilard G, Derjuga A, et al. Endoplasm reticulum association and N-linked glycosylation of the human Nrf3 transcription factor [ J ]. FEBS Lett, 2007, 581 (28): 5401 -5406.

共引文献3

同被引文献21

  • 1李彦杰,李社宣.赵国华治疗帕金森病经验[J].光明中医,2004,19(4):42-43. 被引量:13
  • 2刘雨清,张伟栋,李媛媛.一种新的帕金森病动物模型[J].中国实验动物学报,2007,15(2):159-160. 被引量:9
  • 3李桂源.病理生理学[M].北京:人民卫生出版社,2010:12.
  • 4Peruche B, Krieglstein J. Neuroblastoma cells for test- ing neuroprotective effects [J]. J Pharmcacol Meth, 1991, 23 (1): 63-7.
  • 5Baker SA, Baker KA, Hagg T. Dopaminergic nigrost riatal projections regulate neural precursor proliferation in the adultmouse subvent ricular zone [J]. Eur J Neu- rosci, 2004, 20(2): 575-9.
  • 6Bofoco E, Krainc D, Ankarcrona M, et al. Apoptosis and necrosis: Two distinct events induced, respectively, by mind and intense insuhs with N-methyl-D-aspartate or nitric oxide/superoxidc in conical cell culture[J]. Proc Natl Acad Sci, 1995, 92(16): 7162-6.
  • 7Saito Y, Nishio K, Ogawa Y. Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC 12 cells: involvement of hydrogen peroxide-dependent and -in- dependent aetion [J]. Free Radictd Biol Med. 200% 42 (5): 675-85.
  • 8Ghobrial IM, Witzing TE, Adjei AA, et al. Targeting apoptosis pathways in cancer therapy [J]. CA Cancer J Clin, 2005, 5(3): 178-94.
  • 9Mochizuki H,Goto K, Mori H, et al. Histochemical detec- tion of apoptosis in Parkinson's disease [ J]. J Neurol Sci, 1996,137(2) : 120 - 123.
  • 10Yan Xiang Yang,Nicholas W. Wood,David S. Latchman.Molecular basis of Parkinson?s disease[J]. NeuroReport . 2009 (2)

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部